CSL's biggest bet was a long haul : comparemela.com

The science is clear: health concerns associated with the obesity epidemic are growing. CSL is capitalising on this trend with its $16.4 billion purchase of Vifor Pharma.

Related Keywords

United States , Mexico , Australia , Switzerland , Mexican , Australian , America , American , Swiss , Mark Warburton , David Stanton , Aventis Behring , Abbas Hussain , Tash Sorensen , Vlado Perkovich , Martin Ebner , Sandoz Inc , Credit Suisse , Goldman Sachs , Fresenius Medical Care , Steve Wheen , Brian Mcnamee Led , Middle East , Mylan Laboratories , Border Protection ,